Properties (15)
- purpleRed
- The Melody of Discomfort
- (Shamla et al., 2025)
•
The Melody of Discomfort: Exploring Misophonia - A Case Series
Status:: #status/Bare-bones-review
Metadata
- Item Type: #journalArticle
- Authors:: Fatima Shamla, Jaideep Patil, Suprakash Chaudhury, Bhushan Chaudhari, Suvayan Saha,
- Date:
- Date Added: 1764877192000
- URL: https://journals.lww.com/10.4103/mjdrdypu.mjdrdypu_303_24
- DOI: 10.4103/mjdrdypu.mjdrdypu_303_24
- Cite Key: shamlaMelodyDiscomfortExploring2025
- Topics: [object Object]
- Tags:: #Misophonia, #Bare-bones-review-🦴, #trigger-sounds, #case-report,
- PDF Attachments
Abstract
| Background/Purpose | Background- • Misophonia, though not currently recognized in DSM-5 or ICD-11, involves intense negative reactions to specific sounds and is often misunderstood. • The condition differs from hyperacusis and phonophobia in emotional and physiological response profiles. • A 2022 expert consensus defined misophonia as a standalone disorder. • Neuroimaging studies suggest misophonia is associated with increased activity in the anterior insular cortex and amygdala, suggesting abnormal emotional processing circuits. • Misophonia is frequently comorbid with psychiatric disorders such as OCD, anxiety, and depression. Purpose- • To present three clinical case reports of individuals with misophonia symptoms and describe their diagnostic profiles and therapeutic responses. • To highlight the potential for pharmacological and behavioral interventions in misophonia management. |
| Participants/samples | • N = 3 patients (2 female, 1 male), ages ranging from 32 to 49. • All were middle- to upper-class individuals from urban India. • All had comorbid OCD diagnoses. |
| Measures | • Misophonia Response Scale (scores: 37, 40, 39 for cases 1–3 respectively). |
| Procedures | All patients underwent psychiatric evaluations and were treated with medications (SSRIs, clonazepam, propranolol) and non-pharmacologic therapies (CBT, relaxation techniques). |
| Results | • All three patients demonstrated significant sensitivity to specific sounds, leading to anxiety, preoccupation, and social/occupational dysfunction. • Pharmacologic intervention with SSRIs (fluoxetine or sertraline) and behavioral therapy (CBT and relaxation training) led to varying degrees of symptom improvement: • Case 1: Near-total symptom remission after 4 months. • Case 2: Recurrent symptoms seasonally; temporary relief with medication. • Case 3: Sustained improvement over 2 years with reduced medication. |
| Discussion/Limits | Conclusion- • Misophonia involves distressing, trigger-specific emotional and physiological responses, often overlapping with OCD. • Treatment involving SSRIs and CBT appears effective, though large-scale, controlled studies are lacking. • The presence of anticipatory anxiety and hypervigilance was common across cases. • Misophonia significantly disrupts functioning, yet lacks formal psychiatric recognition or treatment guidelines. |
| Limitations:: | • Small sample size (case series). • No objective physiological or neuroimaging data were collected. • Longitudinal data limited to follow-up in Case 3. |
| Future Directions:: | • Investigate the pathophysiological basis (e.g., brain connectivity abnormalities). • Establish standardized diagnostic criteria and therapeutic protocols. • Evaluate pharmacological vs. behavioral treatments in controlled trials. • Explore misophonia's relation to other sensory sensitivities and comorbidities |
| Relevance:: | • a collection of descriptive case studies of people (N =3) with Misophonia, describing their symptoms, diagnostic profiles ,and treatment responses. • all three were assessed with the Misophonia response Scale to be categorized as Misophonic. • all three were diagnosed with OCD by the author and treated with combos of CBT and medication (one or more of the following: fluoxetine, clonazepam, propranolol), sertraline. they all showed improvements but it is unclear if this is a true Misophonia thing or the result of treating co occurring OCD. • A decent source for example case studies. could be useful to highlight the need to separate co occurring disorders like OCD. |
Notes
Key terms and concepts
-
Misophonia – A condition marked by intense emotional and physiological responses (e.g., anger, anxiety, disgust) to specific trigger sounds such as chewing, breathing, or tapping.
-
Phonophobia – A sound-related disorder distinct from misophonia, characterized by fear-based reactions to specific sounds.
-
Hyperacusis – Heightened sensitivity to sound volume or frequency, distinct from the emotionally charged responses seen in misophonia.
-
Misophonia Response Scale – A standardized scale used to quantify an individual's sensitivity to misophonic triggers.
-
Selective Serotonin Reuptake Inhibitors (SSRIs) – A class of antidepressants (e.g., fluoxetine, sertraline) used as part of the pharmacological treatment for misophonia-related symptoms.
-
CBT (Cognitive Behavioral Therapy) – A structured, evidence-based psychotherapy often used to manage obsessive-compulsive disorder and misophonia
my engagement notes
my questions
my comments
Bookmarks
reading notes
Misc notes
Comorbidity Patterns
-
All patients had OCD, underscoring a strong correlation.
-
Misophonia may also co-occur with mood disorders, PTSD, ADHD, Tourette’s, and eating disorders.
Treatment Stratification
-
Exposure and response prevention is promising for anxiety-dominant misophonia.
-
Cognitive restructuring may be better for anger-dominant cases.
-
Mindfulness and acceptance-based therapies (DBT, ACT) mentioned as potential alternatives.
Functional Impairments
-
Misophonia led to hypervigilance, social withdrawal, and reduced productivity.
-
Patients went to great lengths to avoid triggers (e.g., leaving locations, confrontation, preoccupation)